News | July 31, 2023
Biogen to acquire Reata Pharmaceuticals
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
The product basket increased to 1800 medicines and 285 Surgical Equipment
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Subscribe To Our Newsletter & Stay Updated
